Literature DB >> 28467897

Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations.

Ping Zhong1, Zhixing Hu1, Houbo Jiang1, Zhen Yan2, Jian Feng3.   

Abstract

Locomotor symptoms in Parkinson's disease (PD) are accompanied by widespread oscillatory neuronal activities in basal ganglia. Here, we show that activation of dopamine D1-class receptors elicits a large rhythmic bursting of spontaneous excitatory postsynaptic currents (sEPSCs) in midbrain neurons differentiated from induced pluripotent stem cells (iPSCs) of PD patients with parkin mutations, but not normal subjects. Overexpression of wild-type parkin, but not its PD-causing mutant, abolishes the oscillatory activities in patient neurons. Dopamine induces a delayed enhancement in the amplitude of spontaneous, but not miniature, EPSCs, thus increasing quantal content. The results suggest that presynaptic regulation of glutamatergic transmission by dopamine D1-class receptors is significantly potentiated by parkin mutations. The aberrant dopaminergic regulation of presynaptic glutamatergic transmission in patient-specific iPSC-derived midbrain neurons provides a mechanistic clue to PD pathophysiology, and it demonstrates the usefulness of this model system in understanding how mutations of parkin cause movement symptoms in Parkinson's disease.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease; dopamine; dopaminergic neurons; excitatory postsynaptic currents; induced pluripotent stem cells; oscillation; parkin

Mesh:

Substances:

Year:  2017        PMID: 28467897      PMCID: PMC5492970          DOI: 10.1016/j.celrep.2017.04.023

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  36 in total

1.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

Review 3.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

4.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 5.  Modulation of striatal projection systems by dopamine.

Authors:  Charles R Gerfen; D James Surmeier
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

6.  Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain.

Authors:  Lara Fallon; France Moreau; Benjamin G Croft; Noura Labib; Wen-Jie Gu; Edward A Fon
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

Review 7.  Basal ganglia local field potential activity: character and functional significance in the human.

Authors:  Peter Brown; David Williams
Journal:  Clin Neurophysiol       Date:  2005-07-18       Impact factor: 3.708

Review 8.  Oscillations and the basal ganglia: motor control and beyond.

Authors:  John-Stuart Brittain; Peter Brown
Journal:  Neuroimage       Date:  2013-05-25       Impact factor: 6.556

9.  Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.

Authors:  Monica Joch; Ariel R Ase; Carol X-Q Chen; Penny A MacDonald; Maria Kontogiannea; Amadou T Corera; Alexis Brice; Philippe Séguéla; Edward A Fon
Journal:  Mol Biol Cell       Date:  2007-06-06       Impact factor: 4.138

Review 10.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

View more
  16 in total

1.  Inhibition of Histone Methyltransferases EHMT1/2 Reverses Amyloid-β-Induced Loss of AMPAR Currents in Human Stem Cell-Derived Cortical Neurons.

Authors:  Lin Lin; Aiyi Liu; Hanqin Li; Jian Feng; Zhen Yan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

Review 3.  iPS cells in the study of PD molecular pathogenesis.

Authors:  Melanie M Cobb; Abinaya Ravisankar; Gaia Skibinski; Steven Finkbeiner
Journal:  Cell Tissue Res       Date:  2017-12-12       Impact factor: 5.249

4.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

Review 5.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

Review 6.  Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.

Authors:  Nick Marotta; Soojin Kim; Dimitri Krainc
Journal:  Expert Opin Drug Discov       Date:  2020-01-03       Impact factor: 6.098

7.  Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons.

Authors:  Yong Ren; Houbo Jiang; Jiali Pu; Li Li; Jianbo Wu; Yaping Yan; Guohua Zhao; Thomas J Guttuso; Baorong Zhang; Jian Feng
Journal:  Mov Disord       Date:  2021-09-26       Impact factor: 10.338

8.  In Vitro Differentiated Human Stem Cell-Derived Neurons Reproduce Synaptic Synchronicity Arising during Neurodevelopment.

Authors:  Filip Rosa; Ashutosh Dhingra; Betül Uysal; G Dulini C Mendis; Heidi Loeffler; Gina Elsen; Stephan Mueller; Niklas Schwarz; Melissa Castillo-Lizardo; Claire Cuddy; Felicitas Becker; Peter Heutink; Christopher A Reid; Steven Petrou; Holger Lerche; Snezana Maljevic
Journal:  Stem Cell Reports       Date:  2020-06-18       Impact factor: 7.765

Review 9.  Modeling the pathophysiology of Parkinson's disease in patient-specific neurons.

Authors:  Jian Feng
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-24

10.  Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse.

Authors:  Maria Regoni; Letizia Zanetti; Stefano Comai; Daniela Mercatelli; Salvatore Novello; Federica Albanese; Laura Croci; Gian Giacomo Consalez; Andrea Ciammola; Flavia Valtorta; Michele Morari; Jenny Sassone
Journal:  Biomedicines       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.